Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium vs remifentanil for intubation conditions in elderly patients
2019-004121-25Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing Rocuronium arm with Remifentanil arm (2 arms). Primary endpoint: Excellent intubating conditions. Started Nov 2019; status: completed.
02
Drugs
rocuroniumremifentanil
Beyond the preview
Go deeper on 2019-004121-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004121-25.